A Randomized Controlled Trial of 24-Weeks of Varenicline for Tobacco Use among Cancer Patients: Efficacy, Safety, and Adherence

OBJECTIVE: Continuing to smoke after a cancer diagnosis undermines prognosis. Yet, few trials have tested FDA-approved tobacco use medications in this population. Extended use varenicline may represent an effective treatment for cancer patients who smoke given barriers to cessation including a prolo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Psychooncology
Autors principals: Schnoll, Robert, Leone, Frank, Veluz-Wilkins, Anna, Miele, Andrew, Hole, Anita, Jao, Nancy C., Paul Wileyto, E., Carroll, Allison J., Kalhan, Ravi, Patel, Jyoti, Langer, Corey, Lubitz, Su Fen, Hitsman, Brian
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936106/
https://ncbi.nlm.nih.gov/pubmed/30680852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pon.4978
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars